The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
Contera Pharma will receive an upfront payment and full research funding for each target under investigation
Marks first international filing for Evofem’s single-dose oral treatment
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
